Our Team
Gaurav Aggarwal, M.D.
Principal
Dr. Aggarwal is a principal in the firm and focuses on life sciences investments. He joined JPMorgan Partners in 2004. From 1999 to 2004, he was employed by KBL Healthcare Ventures, most recently as Vice President, where he also focused on venture capital investments in biopharmaceutical and medical device companies. Dr. Aggarwal was involved with KBL's investments in Avalon Pharmaceuticals, ISTA Pharmaceuticals, Neuronetics, and Spinal Concepts, and was a board observer at each company. He was also involved with KBL's investments in Achillion Pharmaceuticals, Corixa Corporation and Scynexis. From 1997 to 1999, Dr. Aggarwal was in the venture capital group at Wasserstein Perella & Co. Dr. Aggarwal received his M.D. from Columbia University, College of Physicians & Surgeons and his B.S. in Business Management from Cornell University. He currently serves on the board of directors of Piramed Limited and Flowcardia, and is a board observer at Innovative Spinal Technologies, Kemia and Presidio Pharmaceuticals. He previously served on the board of directors at Microscience Investments Limited.